|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,380.35 INR | +0.49% |
|
+4.51% | +14.02% |
| 06/05 | Algorae Pharmaceuticals executes license & supply agreement with Torrent Pharma | RE |
| 10/04 | Torrent Pharma says USFDA inspected its Bileshwarpura (oncology) facility from 06-Apr-26 to 10-Apr-26 | RE |
| Capitalization | 1,48300Cr 1.57TCr 1.33TCr 1.22TCr 1.15TCr 2.15TCr 2.17TCr 14TCr 5.64TCr 71TCr 5.89TCr 5.77TCr 2,45900Cr | P/E ratio 2026 * |
68.7x | P/E ratio 2027 * | 67.6x |
|---|---|---|---|---|---|
| Enterprise value | 1,61500Cr 1.71TCr 1.45TCr 1.33TCr 1.26TCr 2.34TCr 2.36TCr 16TCr 6.15TCr 78TCr 6.42TCr 6.28TCr 2,67900Cr | EV / Sales 2026 * |
11.6x | EV / Sales 2027 * | 8.39x |
| Free-Float |
28.87% | Yield 2026 * |
0.67% | Yield 2027 * | 0.71% |
Last Transcript: Torrent Pharmaceuticals Limited
| 1 day | +0.49% | ||
| 1 week | +4.51% | ||
| Current month | +4.51% | ||
| 1 month | +7.02% | ||
| 3 months | +9.63% | ||
| 6 months | +22.37% | ||
| Current year | +14.02% |
| 1 week | 4,213.4 |  | 4,437 |
| 1 month | 4,067.35 | | 4,437 |
| Current year | 3,724.1 | | 4,479.7 |
| 1 year | 3,103 | | 4,479.7 |
| 3 years | 1,599 | | 4,479.7 |
| 5 years | 1,242.5 | | 4,479.7 |
| 10 years | 571.75 | | 4,479.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Aman Samir Mehta
CEO | Chief Executive Officer | 34 | 01/08/2025 |
Sudhir Menon
DFI | Director of Finance/CFO | - | 01/09/2018 |
Hasmukh Patel
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 62 | 30/07/2014 | |
| Director/Board Member | 46 | 08/02/2018 | |
Nayantara Bali
BRD | Director/Board Member | 59 | 07/03/2019 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.49% | +4.51% | +39.61% | +165.58% | 1.57TCr | |
| -2.72% | -1.54% | +29.12% | +121.40% | 85TCr | |
| -0.53% | -2.58% | +43.51% | +37.42% | 53TCr | |
| -0.57% | -2.44% | +9.18% | +37.27% | 36TCr | |
| -0.94% | -0.97% | +22.40% | +11.18% | 32TCr | |
| +0.23% | -1.24% | +30.31% | +12.00% | 28TCr | |
| +0.05% | -2.19% | +24.69% | +21.29% | 28TCr | |
| -0.82% | -0.70% | +46.61% | -5.15% | 28TCr | |
| -1.76% | +4.42% | -34.66% | -49.15% | 20TCr | |
| +0.79% | +0.57% | +24.76% | +41.49% | 18TCr | |
| Average | -0.58% | -0.22% | +23.55% | +39.33% | 32.91TCr | |
| Weighted average by Cap. | -1.05% | -1.24% | +25.70% | +44.81% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 14TCr 146.84Cr 124.76Cr 114.17Cr 107.76Cr 201.01Cr 202.79Cr 1.35TCr 527.95Cr 6.66TCr 550.9Cr 539.32Cr 23TCr | 19TCr 201.4Cr 171.11Cr 156.6Cr 147.8Cr 275.7Cr 278.13Cr 1.86TCr 724.12Cr 9.14TCr 755.6Cr 739.71Cr 32TCr |
| Net income | 2.24TCr 24Cr 20Cr 18Cr 17Cr 32Cr 33Cr 218.34Cr 85Cr 1.07TCr 89Cr 87Cr 3.71TCr | 2.43TCr 26Cr 22Cr 20Cr 19Cr 35Cr 36Cr 237.29Cr 93Cr 1.17TCr 97Cr 94Cr 4.03TCr |
| Net Debt | 13TCr 140.76Cr 119.59Cr 109.45Cr 103.3Cr 192.69Cr 194.39Cr 1.3TCr 506.09Cr 6.39TCr 528.1Cr 516.99Cr 22TCr | 11TCr 119.09Cr 101.18Cr 93Cr 87Cr 163.03Cr 164.47Cr 1.1TCr 428.19Cr 5.4TCr 446.8Cr 437.41Cr 19TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/26/08 | 4,380.35 ₹ | +0.49% | 3,654 |
| 07/26/07 | 4,358.95 ₹ | +0.03% | 4,741 |
| 06/26/06 | 4,357.50 ₹ | +1.91% | 22,623 |
| 05/26/05 | 4,275.95 ₹ | +0.56% | 19,918 |
| 04/26/04 | 4,252.05 ₹ | +1.44% | 53,458 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 500420 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition